Last reviewed · How we verify

NCT06611761

Prospective Observational Study on the Analgesic Effectiveness of Blocking the Suprascapular and Axillary Nerves in Shoulder Arthroscopy.

Completed Last updated 26 September 2024
What this trial tests

trial testing Shoulder arthroscopy in Analgesia in 166 participants. Completed in 2 September 2024.

Timeline
12 October 2023
Primary endpoint
2 September 2024
2 September 2024

Quick facts

Lead sponsorJose Manuel López González
StatusCompleted
Study typeOBSERVATIONAL
Enrollment166
Start date12 October 2023
Primary completion2 September 2024
Estimated completion2 September 2024
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Jose Manuel López González

Who can join

18 and older, any sex, with Analgesia or Shoulder Arthropathy Associated With Other Conditions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study was to evaluate the analgesic efficacy of suprascapular and axillary nerve block for shoulder arthroscopy surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Analgesia

Currently open trials in the same condition.

Other Jose Manuel López González trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06611761.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing